The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison-Reference-Cited by-同舟云学术

The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison

Published:2008-11 Issue:9 Volume:102 Page:1068-1073
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

van den Bergh Roderick C.N.,Roobol Monique J.,Wolters Tineke,van Leeuwen Pim J.,Schröder Fritz H.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07940.x/fullpdf

Reference23 articles.

1. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review;Schroder;Eur Urol,2008

2. 2 Cancer Risk Calculator for Prostate Cancer (Based on the PCPT). Available at: http://www.compass.fhcrc.org/edrnnci/bin/calculator/main.asp. Accessed July 2008

3. 3 Prostate Risk Indicator (based on ERSPC). Available at: http://www.prostate-riskindicator.com/via.html. Accessed July 2008

4. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial;Thompson;J Natl Cancer Inst,2006

5. 5 Kranse R , Roobol MJ , Schroder FH . A graphical device to represent the outcomes of a logistic regression analysis, an illustration of its possible use in prostate cancer screening and prostate cancer treatment counselling. Prostate 2008 (in press)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer;The British Journal of Radiology;2022-11-01

2. A prostate cancer risk calculator (PCRC-MRI): Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men;Canadian Urological Association Journal;2021-06-28

3. Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis;Cancers;2020-12-16

4. A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort;BMC Medical Informatics and Decision Making;2020-07-03

5. Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort;World Journal of Urology;2019-09-14